市場調查報告書
商品編碼
1422723
光學基因組圖譜市場 - 按產品與服務、應用、解決方案、最終用戶、全球預測,2024-2032 年Optical Genome Mapping Market - By Products & Services, Application, Solution, End-user, Global Forecast, 2024-2032 |
由於基因組學研究的持續技術進步,全球光學基因組圖譜 (OGM) 市場從 2023 年到 2032 年的CAGR將達到 24.1%。不斷擴大的基因組分析數位平台將擴大市場規模,為研究人員提供增強的綜合基因組作圖工具。隨著 DNA 定序技術的突破以及 OGM 在包括個人化醫療在內的各種應用中的日益整合,市場將見證大幅擴張,因為它滿足了基因組學研究和診斷能力不斷變化的需求。
例如,2023 年,Bionano Genomics, Inc. 推出了專為高通量光學基因組作圖 (OGM) 設計的 Stratys (TM) 系統以及 VIA (TM) 軟體。此整合軟體平台有助於微陣列、OGM 和次世代定序 (NGS)資料的基因組分析的可視化、解釋和報告。此次發布有望透過在單一平台上提供高通量基因組分析和全面資料解釋的整合解決方案來推動光學基因組作圖 (OGM) 產業的發展。
光學基因組作圖 (OGM) 產業根據最終用途、解決方案和區域進行細分。
在 OGM 技術在藥物發現、基因組學研究和個人化醫療計劃中日益整合的推動下,製藥和生物技術公司細分市場將在 2023 年至 2032 年間獲得顯著的市場佔有率。隨著製藥和生物技術公司利用 OGM 進行精確的基因組分析,該領域對先進解決方案的需求將會激增。 OGM 在增強藥物開發過程中的強大應用將使其成為該市場的重要驅動力。
由於擴大採用 OGM 技術進行全面的基因組分析和組裝,基因組組裝領域將在 2032 年獲得顯著的光學基因組圖譜 (OGM) 市場佔有率。隨著研究人員和醫療保健專業人員優先考慮準確和高解析度的基因組資料,基因組組裝領域將經歷大幅成長。該細分市場在推進基因組學研究和個人化醫療方面發揮著至關重要的作用,將成為塑造光學基因組圖譜市場軌跡的關鍵驅動力。
由於該地區日益關注基因組學研究、醫療基礎設施的進步以及生物技術投資的增加,亞太地區光學基因組圖譜 (OGM) 行業佔有率從 2023 年到 2032 年將以顯著的CAGR成長。隨著亞太地區國家優先考慮精準醫療和個人化基因組學,對 OGM 技術的需求將會激增。該地區對基因組進步的承諾將使其成為光學基因組圖譜市場成長和發展的關鍵貢獻者。
Global Optical Genome Mapping (OGM) Market will register a 24.1% CAGR from 2023 to 2032, attributed to continuous technological advancements in genomics research. The expanding array of digital platforms for genomic analysis will drive market size, offering researchers enhanced tools for comprehensive genome mapping. With breakthroughs in DNA sequencing technologies and the increasing integration of OGM in various applications, including personalized medicine, the market will witness substantial expansion as it meets the evolving demands of genomics research and diagnostic capabilities.
For instance, in 2023, Bionano Genomics, Inc. unveiled the Stratys™ system, designed for high-throughput optical genome mapping (OGM), along with VIA™ software. This integrated software platform facilitates the visualization, interpretation, and reporting of genome analysis for microarrays, OGM, and next-generation sequencing (NGS) data. The launch promises to bolster the optical genome mapping (OGM) industry by offering an integrated solution for high-throughput genome analysis and comprehensive data interpretation on a single platform.
The optical genome mapping (OGM) industry is segmented based on end-use, solution, and region.
The pharmaceutical and biotechnology companies segment will gain a noteworthy market share between 2023 and 2032, driven by the increasing integration of OGM technologies in drug discovery, genomics research, and personalized medicine initiatives. As pharmaceutical and biotechnology firms leverage OGM for precise genomic analysis, the demand for advanced solutions in this segment will surge. The robust applications of OGM in enhancing drug development processes will position it as a vital driver in this market.
The genome assembly segment will secure a notable optical genome mapping (OGM) market share by 2032, propelled by the increasing adoption of OGM technologies for comprehensive genome analysis and assembly. As researchers and healthcare professionals prioritize accurate and high-resolution genomic data, the genome assembly segment will experience substantial growth. With its crucial role in advancing genomics research and personalized medicine, this segment will stand as a key driver in shaping the trajectory of the optical genome mapping market.
Asia-Pacific optical genome mapping (OGM) industry share will grow at a significant CAGR from 2023 to 2032 due to the region's increasing focus on genomics research, advancements in healthcare infrastructure, and rising investments in biotechnology. As countries in the APAC region prioritize precision medicine and personalized genomics, the demand for OGM technologies will surge. The region's commitment to genomic advancements will position it as a pivotal contributor to the growth and development of the optical genome mapping market.